Member Info for Coffee73

Anyone any idea why the recent fall. Really like the potential, I'm thinking lack of news on affirmers and new tests for sensipod. Discussion welcome

Sorry have to disagree. Thought it was nine sales in 6 months which were a lot higher than last year though if I remember correctly last year was poor as customers waited for the new release. I think the fact that revenue has started to come in for affirmers is a good sign and as biotech's start to understand the benefits of the arrays, sales should climb. With good profit margins this should lead to profits also climbing. Don't forget Affirmers are cheaper and quicker than the current alternative. This just needs communicating to the market which I admit will take time but the news will spread out. Another few tests for the sensipod and this should also help drive sales. Long term hold with a slow pick up in share price and sales as each new test is launched. Hopefully.

Anybody with an opinion on why they are having a teach in. Do they think the shares are undervalued or do they want to raise some cash?

Hi all, Anybody know who Paul Brewer is / represents ?

Thanks for that Wisheyedbortum. Nice and informative.

Sorry for being thick but what's happening on August 6th and where did the £125 million revenue figure come from?

There seems to be chatter that they may need to raise capital towards the end of this year. Agree that the price seems to have fallen by about 50% when there has not been any real bad news. Yes sales fell but this was due to customers waiting for the launch of the updated product for which they have already received orders for. A statement from the company regarding finance or first commercial sales of the AX.1 should help stabilise the share price at the minimum. Here's hoping. Still think that down the line 2014 onwards this company has a great future and if things are not as bad as the fall in sp is indicating then their investor relations department could do with a bit of a revamp.

Does anybody know if Avacta has actually started to sell the AX.1 to vets yet?